Intravitreal injection of triamcinolone: Comparison between patients with branch retinal vein occlusion, central retinal vein occlusion and diabetic macular edema

被引：0

作者：

J. Wagner

S. Sacu

K. Krepler

S. Richter-Müksch

E. Ergun

M. Stur

A. Wedrich

机构：

[1] Medizinische Universität Wien, Abt. Augenheilkunde und Optometrie, Wien

[2] Medizinische Universität Wien, Klin. Augenheilkunde und Optometrie, 1090 Wien

来源：

Spektrum der Augenheilkunde | 2005年 / 19卷 / 1期

关键词：

Diabetes mellitus; Intravitreal; Macular edema; Retinal vein occlusion; Triamcinolone;

D O I：

10.1007/BF03163196

中图分类号：

学科分类号：

摘要：

Background: To evaluate the influence of intravitreal triamcinolone acetonide on visual acuity and macular thickness of patients with vascular diseases and macular edema. Methods: Patients with branch retinal vein occlusion (group A: 9 patients), with central retinal vein occlusion (group B: 13 patients) and patients with diabetic macular edema (group C: 12 patients) were included. Patients received an intravitreal injection of 4 mg triamcinolone acetonide. Follow-up examinations were performed at 1 day preoperatively, 1 week, 1 month, 3, 6 (group A) and 9 months (group B and C) after surgery and included Slit-lamp examination, assessment of intraocular pressure determined by Goldmann applanation tonometry, distance visual acuity (BCVA for distance vision in LogMar), near visual acuity (BCVA for near vision in LogRad) and macular thickness using optical coherence tomography (OCT). Results: A significant effect on visual acuity and macular thickness could be observed in all groups. Conclusion: The significant effect of a single intravitreal injection lasted for a maximum of 6 months. Randomized studies are needed to clarify if intravitreal triamcinolone acetonide may be a therapeutic option for certain groups of patients. © Springer-Verlag 2005.

引用

页码：18 / 22

页数：4

共 18 条

[1]

Orth D.H., Patz A., Retinal branch vein occlusion, Surv Ophthalmol, 22, pp. 357-376, (1978)

[2]

Michels R.G., Gass J.D., The natural course of retinal branch vein obstruction, Trans Am Acad Ophthalmol Otolaryngol, 78, (1974)

[3]

Gutman F.A., Zegarra H., The natural course of temporal retinal branch vein occlusion, Trans Am Acad Ophthalmol Otolaryngol, 78, (1974)

[4]

Argon laser photocoagulation for macular edema in branch vein occlusion, Am J Ophthalmol, 98, pp. 271-282, (1984)

[5]

Zegarra H., Gutman F.A., Conforto J., The natural course of central retinal vein occlusion, Ophthalmology, 86, pp. 1931-1942, (1979)

[6]

Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion, Ophthalmology, 102, pp. 1425-1433, (1995)

[7]

Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1, Arch Ophthalmol, 103, pp. 1796-1806, (1985)

[8]

Lee C.M., Olk R.J., Modified grid laser photocoagulation for diffuse diabetic macular edema, Ophthalmology, 98, pp. 1594-1602, (1991)

[9]

Jonas J.B., Akkoyun I., Kamppeter B., Kreissig I., Degenring R.F., Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide, Eye, 19, pp. 65-71, (2005)

[10]

Chen S.D.M., Lochhead J., Patel C.K., Frith P., Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch retinal vein occlusion, Br J Ophthalmol, 88, pp. 154-155, (2004)

← 1 2 →